The European Investment Bank (EIB) has waived the put option attached to the warrants granted in connection with the €40 ...

GLP-1 medications have transformed the weight loss landscape, with options now available as both weekly injections and daily pills. But the big question remains: are oral GLP-1 drugs just as effective ...

Pregnant patients with opioid use disorder (OUD) who received subcutaneous extended-release buprenorphine had higher rates of abstinence from illegal opioids than those who received the sublingual ...

Grey-market injectable peptides – a category of substances with obscure, alphanumeric names such as BPC-157, GHK-Cu, or TB-500 – have developed a devoted following among biohackers and health ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

The latest wellness craze to take social media by storm is fuelling a growing grey market of injectable peptides in Australia, and it has experts worried. Promises of tanned youthful skin, weight loss ...

With this label update, patients and their healthcare professionals can work together to decide the most suitable choice of administration. 1 It applies to all ten therapeutic indications of ...

The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...

A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Peptides have become a buzzy wellness trend, promoted ...